Weight Loss Medications
FDA-Approved Weight Loss Medications in Gulfport, MS
Phentermine In Gulfport, MS
Phentermine HCL is the generic form of an appetite suppressant drug, Adipex, approved by the FDA in 1959. In recent years, it is most often prescribed by Obesity Medicine specialists in conjunction with nutritional intervention and lifestyle modification to aid patients suffering from the chronic medical conditions of Overweight and Obesity and their associated comorbidities.
Wegovy™
Wegovy™ (semaglutide) injection 2.4 mg is an injectable prescription medicine used for adults with obesity (BMI ≥30) or overweight (excess weight) (BMI ≥27) who also have weight-related medical problems to help them lose weight and keep the weight off.
- Wegovy™ should be used with a reduced-calorie meal plan and increased physical activity.
- Wegovy™ contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
- It is not known if Wegovy™ is safe and effective when taken with other prescription, over-the-counter, or herbal weight-loss products.
- It is not known if Wegovy™ can be used safely in people with a history of pancreatitis.
- It is not known if Wegovy™ is safe and effective for use in children under 18 years of age.
Ozempic®
Ozempic® is a medicine for adults with type 2 diabetes that, along with diet and exercise, may improve blood sugar. While not for weight loss, Ozempic® may help you lose some weight.
- Ozempic® is proven to lower A1C
- Ozempic® lowers risk of major cardiovascular events such as stroke, heart attach, or death in adults also with known heart disease.
- Ozempic® May help you loose some weight. Ozempic® is not for weight loss.
Qsymia® In Gulfport, MS
Qsymia® (phentermine and topiramate extended-release) capsules CIV.
Qsymia® is an FDA-approved prescription medicine that may help some obese adults or some overweight adults who also have weight-related medical problems lose weight and keep the weight off.
Qsymia® should be used with a reduced-calorie diet and increased physical activity.
2,487 overweight or obese patients (BMI 27 or greater and less than or equal to 45) with 2 or more weight-related comorbidities were evaluated.
Contrave®
CONTRAVE is a prescription medicine that contains 2 medicines (naltrexone HCl and bupropion HCl) that may help some obese adults, or overweight adults* who also have weight-related medical problems†, lose weight and keep the weight off.
Contrave® is part of the Opioid Antagonist / Atypical Antidepressant Combinations class and treats Weight Loss. Opioid antagonist / atypical antidepressant combination drugs are used in combination with diet and exercise to help with weight loss in obese or overweight patients. They work by decreasing appetite and food intake.
September 2014 Press Release
Deerfield, Ill., and La Jolla, Calif., September 11, 2014 – Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that the U.S. Food and Drug Administration (FDA) has approved Contrave® (naltrexone HCI and bupropion HCI) extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.
Primary and Secondary Outcomes for Participants Completing 56 Weeks Of Contrave Therapy in Two Trials
| Change in body weight (%) | –1.8% | –6.7% | –8.1% | –7.3% | –11.5% |
| Change in body weight (kg) | –1.9 | –6.5 | –8.0 | ||
| Participants with a weight loss of 5% or more | 67 (23%) | 155 (55%) | 183 (62%) | 60.4% | 80.4% |
| Participants with a weight loss of 10% or more | 31 (11%) | 85 (30%) | 102 (34%) | 30.2% | 55.2% |
| Participants with a weight loss of 15% or more | 9 (3%) | 40 (14%) | 51 (17%) | 17.9% | 39.5% |
NBSR = naltrexone SR/bupropion SR combination.
The dose of naltrexone SR is noted in the table (16 and 32 mg). The dose of bupropion SR is fixed at 360 mg/day.
*For all comparisons, P < 0.0001 compared with placebo.
†For all comparisons, P < 0.001.
Health Fit M.D. provides medical weight loss and aesthetic procedures for clients all over the Mississippi Gulf Coast.
Call(228) 206-0542 or book an appointment with our Medical Weight Loss Doctor or Licensed Aesthetician today!
Please note that your appointment will not be fully booked until a member of our staff calls to finalize the appointment.
A $50 booking fee must be paid over the phone to secure your appointment. All fees go towards your first visit.
